Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04806321 · ClinicalTrials.gov registry record · NA

Project SOLVE: Trial of a Brief Digital Problem-solving Intervention

A NA study of Depression and Anxiety, sponsored by Harvard University.

Completed
Registry status
NA
Development phase
522
Enrollment target
1
Study location

NCT04806321 is a NA study of Depression and Anxiety that has completed, run by Harvard University. The registered enrollment target is 522 participants, below the 785-participant average among 679 other Depression trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04806321, a NA study of Depression and Anxiety, has completed, sponsored by Harvard University.

COMPLETED
Registry status
NA
Development phase
522 participants
Enrollment target
1
Study location

Study Summary

The goal of this trial is to examine the effectiveness of a universal, self-guided, digital single-session intervention focusing on problem-solving skills in improving adolescent mental health and well-being, relative to an active control intervention focusing on study skills, within the context of school settings during the coronavirus disease pandemic.

Interventions

  • OTHER Project SOLVE
  • OTHER Project SUCCESS

Study Locations (1)

Massachusetts

  • Harvard University - Cambridge

Trial Details

FieldValue
Enrollment Target 522 participants
Start Date 2021-03-15
Est. Completion 2022-05-15
Phase NA

Sponsor

Harvard University

37 total trials

What the Registry Record Tells You About NCT04806321

The ClinicalTrials.gov registry entry for NCT04806321 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 522 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 785-participant average among 679 other Depression trials with a reported enrollment target (34% lower). The listed sponsor is Harvard University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Project SOLVE is the first listed.

NCT04806321 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04806321 about?

NCT04806321 is a clinical study titled "Project SOLVE: Trial of a Brief Digital Problem-solving Intervention". The goal of this trial is to examine the effectiveness of a universal, self-guided, digital single-session intervention focusing on problem-solving skills in improving adolescent mental health and well-being, relative to an active control intervention focusing on study skills, within the context of ...

What is the current status of trial NCT04806321?

This trial is currently completed. It is a NA study. The enrollment target is 522 participants. The study started on 2021-03-15. Estimated completion is 2022-05-15.

What conditions does trial NCT04806321 study?

This clinical trial studies the following conditions: Depression, Anxiety, Stress.

What interventions are being tested in trial NCT04806321?

The interventions under investigation include: Project SOLVE (OTHER), Project SUCCESS (OTHER).

Who is sponsoring clinical trial NCT04806321?

This trial is sponsored by Harvard University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04806321 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.